Dr. Insel received a M.D. from the U. of Michigan and post-MD training in Internal Medicine at Boston City Hospital/Harvard Service, NIH and UC San Francisco. He then joined UC San Diego and is Emeritus Distinguished Professor of Pharmacology and Medicine. He has received many awards, a Doc. Hon Causa from the University of Paris and is a Fellow of several scientific societies. Dr. Insel has been Editor of multiple scientific journals,currently of the Annual Review of Pharmacology & Toxicology. Dr. Insel’sresearch has focused on G protein-coupled receptors; he has published >300 original articles and >190 invited publications.
Dr. Carl C Peck
University of California at San Francisco
USA
Carl Peck MD is Adjunct Professor, UCSF, and is Cofounder and Expert Consultant of NDA Partners/a ProPharma Company. His career-long interest in quantitative clinical pharmacology is expressed in more than 175 published peer-reviewed publications, book chapters. As former Director of the FDA Center for Drug Evaluation and Research (CDER), he championed incorporation of advanced quantitative clinical pharmacology approaches in regulatory science and medical product development. His contributions have been recognized via an Honorary degree from Sweden's Uppsala University, the 1999 FDA Distinguished Alumnus Award, 2012 ASCPT Gary Neal Prize for Innovation in Drug Development, 2017 ASCPT Sheiner-Beal Pharmacometrics Award, and the 2018 Gary Levy Memorial Lectureship.
